These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36254420)

  • 1. Lipid Profile and Ultrasonographic Grading in Alcoholic and Non Alcoholic Fatty Liver Patients.
    Shahi A; Gautam N; Rawal S; Sharma U; Jayan A
    Kathmandu Univ Med J (KUMJ); 2021 Jul-Sept.; 19(75):334-338. PubMed ID: 36254420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: A retrospective study.
    Li R; Kong D; Ye Z; Zong G; Hu K; Xu W; Fang P; Zhang L; Zhou Y; Zhang K; Xue Y
    Front Endocrinol (Lausanne); 2023; 14():1127134. PubMed ID: 36875464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis.
    Lu S; Xie Q; Kuang M; Hu C; Li X; Yang H; Sheng G; Xie G; Zou Y
    J Transl Med; 2023 Mar; 21(1):192. PubMed ID: 36915168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia.
    Amor AJ; Pinyol M; Solà E; Catalan M; Cofán M; Herreras Z; Amigó N; Gilabert R; Sala-Vila A; Ros E; Ortega E
    J Clin Lipidol; 2017; 11(2):551-561.e7. PubMed ID: 28502513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males.
    Peng K; Mo Z; Tian G
    Am J Med Sci; 2017 Mar; 353(3):236-241. PubMed ID: 28262209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China.
    Wang J; Su Z; Feng Y; Xi R; Liu J; Wang P
    BMC Gastroenterol; 2021 Dec; 21(1):482. PubMed ID: 34923965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.
    Ren XY; Shi D; Ding J; Cheng ZY; Li HY; Li JS; Pu HQ; Yang AM; He CL; Zhang JP; Ma YB; Zhang YW; Zheng TZ; Bai YN; Cheng N
    Lipids Health Dis; 2019 Feb; 18(1):47. PubMed ID: 30744645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study.
    Tutunchi H; Naeini F; Ebrahimi-Mameghani M; Mobasseri M; Naghshi S; Ostadrahimi A
    Int J Clin Pract; 2021 Jun; 75(6):e14131. PubMed ID: 33683797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol.
    Wu KT; Kuo PL; Su SB; Chen YY; Yeh ML; Huang CI; Yang JF; Lin CI; Hsieh MH; Hsieh MY; Huang CF; Lin WY; Yu ML; Dai CY; Wang HY
    J Clin Lipidol; 2016; 10(2):420-5.e1. PubMed ID: 27055973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.
    Lu S; Kuang M; Yue J; Hu C; Sheng G; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):95. PubMed ID: 36207744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children?
    Meng L; Luo N; Mi J
    Biomed Environ Sci; 2011 Feb; 24(1):22-30. PubMed ID: 21440836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease.
    Dowla S; Aslibekyan S; Goss A; Fontaine K; Ashraf AP
    J Clin Lipidol; 2018; 12(4):981-987. PubMed ID: 29699915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of non-alcoholic fatty liver disease and hypercholesterolemia in patients with gallstone disease undergoing laparoscopic cholecystectomy.
    Singh K; Dahiya D; Kaman L; Das A
    Pol Przegl Chir; 2019 Nov; 92(1):18-22. PubMed ID: 32312927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting lipoproteins in nonalcoholic fatty liver disease.
    Nemes K; Åberg F
    Curr Opin Lipidol; 2017 Aug; 28(4):355-360. PubMed ID: 28441156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid profile comparison between pre- and post-menopausal women].
    Wang N; Qin MZ; Cui J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
    [No Abstract]   [Full Text] [Related]  

  • 18. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
    Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
    Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study.
    Rajesh NA; Drishya L; Ambati MMR; Narayanan AL; Alex M; R KK; Abraham JJ; Vijayakumar TM
    J Clin Exp Hepatol; 2022; 12(1):61-67. PubMed ID: 35068786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
    Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
    Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.